Literature DB >> 31757727

[Nutritional Management of Nonalcoholic fatty liver disease (NAFLD)].

Amel Ait Boudaoud1, Claire Rives-Lange2, Jean François Perregaux3, Alina Radu3, Diane Messager-Josipowicz3, Charles Barsamian3, Claire Carette2, Sébastien Czernichow2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with obesity and insulin resistance. There is currently no pharmacological treatment validated in steatosis. The combination of weight loss and adequate physical activity can improve liver steatosis. In randomized trials and cohort studies, a weight loss of at least 7% and a diet approaching the Mediterranean diet have been associated with an improvement in hepatic fat content, an improvement in hepatic biomarkers, and regression of histological signs of steatosis. Bariatric surgery by losing weight can lead to an improvement in hepatic fat content.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31757727     DOI: 10.1016/j.lpm.2019.10.026

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  1 in total

1.  Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.

Authors:  Gai Gao; Zhishen Xie; Er-Wen Li; Yong Yuan; Yu Fu; Pan Wang; Xiaowei Zhang; Yonghui Qiao; Jiangyan Xu; Christian Hölscher; Hui Wang; Zhenqiang Zhang
Journal:  J Nat Med       Date:  2021-02-15       Impact factor: 2.343

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.